Cartesian Therapeutics Inc
NASDAQ:RNAC
Cartesian Therapeutics Inc
NASDAQ:RNAC
Price:
6.93
USD
7.44%
Market Closed
Market Cap:
$183.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cartesian Therapeutics Inc
NASDAQ:RNAC
|
US |
|
Brisbane Broncos Ltd
ASX:BBL
|
AU |
|
C
|
CombinedX AB (publ)
F:K13
|
SE |
|
Scandic Hotels Group AB
STO:SHOT
|
SE |
|
ActiveOps PLC
LSE:AOM
|
UK |
|
Savannah Resources Plc
F:SAV
|
UK |
Wall St Price Targets
RNAC Price Targets Summary
Cartesian Therapeutics Inc
Cartesian Therapeutics Inc
Wall Street analysts forecast RNAC stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for RNAC is 34.85 USD with a low forecast of 16.16 USD and a high forecast of 46.2 USD.
Lowest Forecast
Price Target
16.16
USD
133% Upside
Average Forecast
Price Target
34.85
USD
403% Upside
Highest Forecast
Price Target
46.2
USD
567% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RNAC's stock price target?
Price Target
34.85
USD
34.85
USD
According to Wall Street analysts, the average 1-year price target for RNAC is 34.85 USD with a low forecast of 16.16 USD and a high forecast of 46.2 USD.
What is the Revenue forecast for Cartesian Therapeutics Inc?
Projected CAGR
105%
105%
Over the last 10 years, the compound annual growth rate for Revenue has been -7%. The projected CAGR for the next 8 years is 105%.
